FRIEDREICHS ATAXIA RESEARCH ALLIANCE FARA
Mission Statement
The Friedreich’s Ataxia Research Alliance (FARA) is a national, public, 501(c)(3), non-profit organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich’s ataxia. to marshal and focus the resources and relationships needed to cure FA by raising funds for research, promoting public awareness, and aligning scientists, patients, clinicians, government agencies, pharmaceutical companies and other organizations dedicated to curing FA and related diseases. https://www.curefa.org/why-we-exist/our-mission/ Genetic therapies are treatments that target FA at the DNA level. This is a rapidly growing field. As FA genetic therapy programs move toward clinical trials, understanding how these therapies work can help you make informed decisions about participation.
Financial Overview — FY 2023
Compared with Peers
FY 2023| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
94.9% | 82.7% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
2.7% | 13.5% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
2.4% | 0.0% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
70.6% | 639.6% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
6.1 mo | 12.6 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
20.7% | 29.0% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
107.2% | 91.9% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
1.5% | 7.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
9.6% | 10.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-8.9% | -2.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $11.2M | $12.2M | $6.1M | 94.9% | 17 |
| 2022 | $11.0M | $11.1M | $6.8M | 95.5% | 16 |
| 2021 | $7.7M | $9.1M | N/A | — | 13 |
Donor Reviews
Write a ReviewBe the first to share your experience with this organization.